FILTRIX Logo FILTRIX Find Your Edge β†’
Sector Report β€” Open SIC 2836 Β· 144 tickers

Biological Products, (No Diagnostic Substances)

SIC 2836 144 tickers analyzed 5,947 total alerts

Tickers
144
In this sector
Total alerts
5,947
Trade-Ideas signal history
Avg win rate
43.1%
Sector baseline
Avg gain
-0.39%
Per-alert expectancy

πŸ“ˆ Sector Performance by Timeframe

5-Minute

Avg Gain: -0.28%
Win Rate: 42.0%

15-Minute

Avg Gain: -0.47%
Win Rate: 42.5%

30-Minute

Avg Gain: -0.51%
Win Rate: 42.5%

60-Minute

Avg Gain: -0.54%
Win Rate: 43.4%

EOD

Avg Gain: -0.13%
Win Rate: 45.2%

MFE/MAE

Avg MFE: +6.52%
Avg MAE: -2.61%

πŸ“‹ Biological Products, (No Diagnostic Substances) Stocks (100)

All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.

# Ticker Company Market Cap Alerts Avg Win Rate Avg 5min MFE Action
1 DNA Ginkgo Bioworks Holdings, Inc. $531.5M 446 35.2% -0.60% +4.05% View β†’
2 OCGN Ocugen, Inc. Common Stock $248.6M 418 39.2% -0.51% +3.74% View β†’
3 NVAX Novavax Inc $1.27B 358 44.6% -0.21% +5.10% View β†’
4 RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock $1.70B 287 48.0% -0.11% +4.08% View β†’
5 MRNA Moderna, Inc. Common Stock $80.65B 241 51.7% +0.10% +4.21% View β†’
6 OTLK Outlook Therapeutics, Inc. Common Stock $97.6M 193 43.9% -0.35% +8.11% View β†’
7 IBRX ImmunityBio, Inc. Common Stock $6.99B 188 48.1% -0.37% +7.02% View β†’
8 GILD Gilead Sciences Inc $206.55B 161 55.4% +0.05% +1.25% View β†’
9 PALI Palisade Bio, Inc. Common Stock $166.1M 152 38.8% -0.16% +8.56% View β†’
10 IOVA Iovance Biotherapeutics, Inc. Common Stock $3.38B 121 49.6% +0.19% +5.49% View β†’
11 TNYA Tenaya Therapeutics, Inc. Common Stock $68.0M 116 39.1% -0.49% +4.62% View β†’
12 AIM AIM ImmunoTech Inc. $4.8M 110 47.5% +0.39% +9.36% View β†’
13 HUMA Humacyte, Inc. Common Stock $150.7M 105 43.6% -0.47% +5.64% View β†’
14 AMGN Amgen Inc $237.36B 101 51.1% +0.02% +1.25% View β†’
15 LIMN Liminatus Pharma, Inc. Class A Common Stock $3.8M 100 49.0% -0.17% +9.56% View β†’
16 CLDI Calidi Biotherapeutics, Inc. $1.7M 98 37.2% -0.31% +6.18% View β†’
17 GRML Greenland Mines Ltd. Common Stock $43.1M 80 32.0% -0.42% +8.24% View β†’
18 SGMO SANGAMO THERAPEUTICS INC - 75 44.8% +0.12% +9.76% View β†’
19 CGTX Cognition Therapeutics, Inc. Common Stock $57.1M 74 39.8% -0.74% +7.07% View β†’
20 PHGE BiomX Inc. $5.0M 71 46.7% +0.06% +8.83% View β†’
21 QNCX Quince Therapeutics, Inc. Common Stock $27.3M 70 35.8% -1.54% +10.00% View β†’
22 SNTI Senti Biosciences Holdings, Inc. Common Stock $7.2M 68 38.0% -0.80% +15.20% View β†’
23 PLX Protalix BioTherapeutics, Inc. Common Stock $258.0M 67 44.8% -0.25% +4.61% View β†’
24 SLXN Silexion Therapeutics Corp Ordinary Shares - 65 46.4% -0.19% +11.86% View β†’
25 CELZ Creative Medical Technology Holdings, Inc. Common Stock $3.3M 63 38.0% +0.34% +11.51% View β†’
26 XFOR X4 Pharmaceuticals, Inc. Common Stock $302.3M 58 31.0% -1.96% +8.49% View β†’
27 CHRS Coherus Oncology, Inc. Common Stock $59.8M 58 44.8% -0.19% +6.56% View β†’
28 IVVD Invivyd, Inc. Common Stock $131.8M 53 37.7% -1.02% +11.51% View β†’
29 TVGN Tevogen Inc. Common Stock $432.7M 52 31.5% -0.40% +10.91% View β†’
30 BCAB BIOATLA INC $2.9M 51 42.5% -0.57% +8.60% View β†’
31 BCRX BioCryst Pharmaceuticals Inc $1.88B 49 51.8% -0.53% +4.61% View β†’
32 CCCC C4 Therapeutics, Inc. $320.4M 49 54.3% +0.42% +10.68% View β†’
33 ATRA Atara Biotherapeutics, Inc $64.6M 47 53.5% +0.52% +11.96% View β†’
34 BIIB Biogen Inc. Common Stock $36.53B 45 44.4% -0.32% +1.31% View β†’
35 DBVT DBV Technologies S.A. American Depositary Shares $592.0M 44 34.8% -0.12% +5.94% View β†’
36 AGEN Agenus Inc. $277.8M 43 42.5% -0.79% +6.44% View β†’
37 CRIS Curis Inc $4.5M 43 42.1% -0.47% +10.54% View β†’
38 CMPX Compass Therapeutics, Inc. Common Stock $122.2M 39 50.3% -0.01% +7.05% View β†’
39 SANA Sana Biotechnology, Inc. Common Stock $521.4M 37 33.0% +0.09% +5.08% View β†’
40 CABA Cabaletta Bio, Inc. Common Stock $217.9M 37 45.4% -0.57% +9.24% View β†’
41 CRDF Cardiff Oncology, Inc. Common Stock $69.4M 37 35.9% +0.28% +7.87% View β†’
42 REPL Replimune Group, Inc. $1.82B 36 56.7% -0.25% +9.14% View β†’
43 BCDA BioCardia, Inc. Common Stock $11.7M 35 43.2% -0.28% +9.47% View β†’
44 AUTL Autolus Therapeutics plc American Depositary Share $260.9M 35 38.9% -0.52% +4.93% View β†’
45 TSHA Taysha Gene Therapies, Inc. Common Stock $1.23B 34 39.4% -0.55% +9.44% View β†’
46 VIVS VivoSim Labs, Inc. Common Stock $5.9M 33 33.4% +0.24% +7.01% View β†’
47 RLAY Relay Therapeutics, Inc. Common Stock $3.52B 32 53.1% +0.18% +5.76% View β†’
48 ATYR aTyr Pharma, Inc. Common Stock $9.4M 32 41.9% -0.40% +5.90% View β†’
49 SCLX Scilex Holding Company Common Stock $4.6M 31 33.8% -0.46% +6.87% View β†’
50 SLDB Solid Biosciences Inc. Common Stock $718.8M 30 52.0% -0.30% +8.71% View β†’
51 CVM Cel-Sci Corporation $25.9M 30 36.7% -0.10% +13.01% View β†’
52 CADL Candel Therapeutics, Inc. Common Stock $402.4M 30 51.3% +0.98% +13.71% View β†’
53 INAB IN8bio, Inc. Common Stock $8.3M 29 37.2% -0.66% +10.13% View β†’
54 CRSP CRISPR Therapeutics AG $3.78B 29 47.6% -0.10% +4.39% View β†’
55 DTIL Precision BioSciences, Inc. Common Stock $263.8M 28 30.5% -0.85% +4.42% View β†’
56 BDTX Black Diamond Therapeutics, Inc. Common Stock $79.9M 27 25.9% -1.01% +5.18% View β†’
57 FATE Fate Therapeutics, Inc. $122.9M 27 63.0% +2.27% +9.86% View β†’
58 EDIT Editas Medicine, Inc. Common Stock $263.9M 27 44.4% +0.75% +7.15% View β†’
59 ADMA ADMA Biologics, Inc. $2.96B 26 53.8% +0.18% +5.66% View β†’
60 ALLO Allogene Therapeutics, Inc. Common Stock $231.1M 26 36.2% -0.35% +5.40% View β†’
61 SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares $1.0M 26 38.3% +1.36% +9.96% View β†’
62 KOD Kodiak Sciences Inc Common Stock $6.40B 25 54.4% +0.52% +10.90% View β†’
63 JSPR Jasper Therapeutics, Inc. Common Stock $11.9M 24 40.0% +0.44% +16.82% View β†’
64 RGNX REGENXBIO Inc. $474.8M 24 36.7% -0.59% +4.45% View β†’
65 PRME Prime Medicine, Inc. Common Stock $856.3M 24 49.2% +0.25% +5.90% View β†’
66 IMVT Immunovant, Inc. Common Stock $6.73B 24 55.8% +0.64% +6.88% View β†’
67 IKT Inhibikase Therapeutics, Inc. Common Stock $182.4M 23 30.1% -0.87% +7.69% View β†’
68 CRBU Caribou Biosciences, Inc. Common Stock $33.5M 20 41.0% -0.47% +5.17% View β†’
69 NMRA Neumora Therapeutics, Inc. Common Stock $65.5M 20 51.5% +0.34% +11.53% View β†’
70 BEAM Beam Therapeutics Inc. Common Stock $2.17B 20 54.0% -0.04% +6.06% View β†’
71 INTS Intensity Therapeutics, Inc. Common stock $8.3M 19 30.1% -0.23% +5.87% View β†’
72 AVXL Anavex Life Sciences $61.9M 18 30.0% -0.94% +5.30% View β†’
73 KLTO Klotho Neurosciences, Inc. Common Stock $23.7M 18 41.1% -0.48% +14.35% View β†’
74 ALGS Aligos Therapeutics, Inc. Common Stock $7.8M 17 38.5% -2.19% +7.79% View β†’
75 BNTX BioNTech SE American Depositary Share $20.18B 17 49.4% +0.17% +2.85% View β†’
76 NBIX Neurocrine Biosciences Inc $15.85B 16 62.5% +0.05% +1.77% View β†’
77 RVMD Revolution Medicines, Inc. Common Stock $34.48B 16 42.5% -1.79% +3.88% View β†’
78 TCRX TScan Therapeutics, Inc. Common Stock $9.7M 16 48.1% -0.11% +17.56% View β†’
79 VIR Vir Biotechnology, Inc. Common Stock $1.65B 15 30.7% -1.26% +4.23% View β†’
80 HALO Halozyme Therapeutics, Inc. $10.61B 15 49.2% -0.45% +2.45% View β†’
81 ABOS Acumen Pharmaceuticals, Inc. Common Stock $14.0M 15 32.0% +0.32% +9.47% View β†’
82 SABS SAB Biotherapeutics, Inc. Common Stock $262.2M 15 31.3% -2.10% +11.81% View β†’
83 PCVX Vaxcyte, Inc. Common Stock $9.24B 13 52.3% +0.50% +4.44% View β†’
84 GLUE Monte Rosa Therapeutics, Inc. Common Stock $761.4M 13 41.5% -1.01% +10.67% View β†’
85 KYTX Kyverna Therapeutics, Inc. Common Stock $276.3M 13 35.4% -0.54% +3.39% View β†’
86 INMB INmune Bio Inc. Common stock $27.7M 13 60.0% -0.04% +7.00% View β†’
87 ENTX Entera Bio Ltd. Ordinary Shares $571.2M 13 40.8% -1.91% +21.68% View β†’
88 SRZN Surrozen, Inc. Common $584.6M 12 54.5% -0.22% +14.45% View β†’
89 DNLI Denali Therapeutics Inc. Common Stock $2.92B 12 46.7% -0.57% +3.89% View β†’
90 TECH Bio-Techne Corp. $11.42B 12 50.2% -0.46% +1.46% View β†’
91 LCTX Lineage Cell Therapeutics, Inc. $207.4M 11 24.2% -0.80% +3.40% View β†’
92 INBX Inhibrx Biosciences, Inc. Common Stock $1.10B 11 38.7% -1.12% +4.73% View β†’
93 FDMT 4D Molecular Therapeutics, Inc. Common Stock $604.4M 11 38.2% -2.15% +6.53% View β†’
94 ENGN enGene Therapeutics Inc. Common Stock $117.9M 10 46.9% +1.12% +5.70% View β†’
95 ZURA Zura Bio Limited Class A Ordinary Shares $91.7M 10 48.0% +0.35% +11.71% View β†’
96 APGE Apogee Therapeutics, Inc. Common Stock $10.22B 10 60.0% +1.28% +4.60% View β†’
97 HLSQ TESSERA DEFENSE&HOMELAND $2.4M 10 26.0% -1.03% +4.15% View β†’
98 EXEL Exelixis Inc $16.06B 10 64.0% +0.06% +2.17% View β†’
99 TWST Twist Bioscience Corporation Common Stock $7.61B 10 52.0% -0.01% +6.32% View β†’
100 PASG Passage Bio, Inc. Common Stock $11.6M 9 46.7% +0.26% +11.50% View β†’

πŸš€ Scan for Alpha in Biological Products, (No Diagnostic Substances)

Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 144 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.

Find Best Setups β†’

πŸ“Š Biological Products, (No Diagnostic Substances) Sector Intelligence

⚑ High Volatility Sector

The Biological Products, (No Diagnostic Substances) sector (SIC 2836) aggregates data from 144 stocks. With an average Maximum Favorable Excursion (MFE) of +6.52%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.

πŸ“ˆ Statistical Expectancy

Across 5,947 analyzed alerts, the sector shows a 43.1% Win Rate with an average gain of -0.39%.

⚠️ This suggests a difficult trading environment where strict stock selection is critical. Focus on the top performers within this sector.

πŸ† Sector Leader

The strongest statistical performer in this group is currently EXEL , boasting a 64.0% win rate across 10 alerts.

This significantly outperforms the sector average (43.1%), making it a primary watchlist candidate for traders seeking edge in this space.